
My Genome Screen offers an AI-powered software solution designed to transform genetic diagnosis, particularly for rare diseases. The platform combines an advanced AI module with manually curated in-house models to simplify variant interpretation, even in complex cases, thereby saving time and improving accuracy. By identifying the most relevant genetic variants, My Genome Screen helps clinicians make faster, more precise diagnoses, aiming to bridge the rare disease diagnosis gap where 80% of cases remain undiagnosed. The service accelerates the diagnostic journey for patients, reducing the average time to diagnosis and enabling earlier, preventive medicine strategies. The company also provides carrier screening for prospective parents. The business model appears to be SaaS, with a focus on providing actionable insights from genetic data.

My Genome Screen offers an AI-powered software solution designed to transform genetic diagnosis, particularly for rare diseases. The platform combines an advanced AI module with manually curated in-house models to simplify variant interpretation, even in complex cases, thereby saving time and improving accuracy. By identifying the most relevant genetic variants, My Genome Screen helps clinicians make faster, more precise diagnoses, aiming to bridge the rare disease diagnosis gap where 80% of cases remain undiagnosed. The service accelerates the diagnostic journey for patients, reducing the average time to diagnosis and enabling earlier, preventive medicine strategies. The company also provides carrier screening for prospective parents. The business model appears to be SaaS, with a focus on providing actionable insights from genetic data.